Gilead Sciences (GILD) April weeky calls active on open
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $150.11 -0.52%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.3%
Revenue Growth %: -0.4%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.3%
Revenue Growth %: -0.4%
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) 30-day option implied volatility is at 78; compared to its 52-week range of 19 to 108 amid remdesivir improved 68% research trial study. Call put ratio 5 calls to 1 put.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead expands lenacapavir licensing to cover once-yearly HIV prevention
- Pinduoduo (PDD) call put ratio 5.4 calls to 1 put into President Donald Trump and Chinese President Xi Jinping's summit
- Ginkgo Bioworks (DNA) 4K contracts of December 11 calls trade, share price up 15%
Create E-mail Alert Related Categories
OptionsRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
